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Background. Genetic variation in the gene encoding ZNF804A, a risk gene for schizophrenia, has been shown to affect
brain functional endophenotypes of the disorder, while studies of white matter structure have been inconclusive.
Method. We analysed effects of ZNF804A single nucleotide polymorphism rs1344706 on grey and white matter using
voxel-based morphometry (VBM) in high-resolution T1-weighted magnetic resonance imaging scans of 62 schizophrenia
patients and 54 matched healthy controls.
Results. We found a signiﬁcant (p<0.05, family-wise error corrected for multiple comparisons) interaction effect of
diagnostic group x genotype for local grey matter in the left orbitofrontal and right and left lateral temporal cortices,
where patients and controls showed diverging effects of genotype. Analysing the groups separately (at p<0.001, uncor-
rected), variation in rs1344706 showed effects on brain structure within the schizophrenia patients in several areas includ-
ing the left and right inferior temporal, right supramarginal/superior temporal, right and left inferior frontal, left
frontopolar, right and left dorsolateral/ventrolateral prefrontal cortices, and the right thalamus, as well as effects within
the healthy controls in left lateral temporal, right anterior insula and left orbitofrontal cortical areas. We did not ﬁnd
effects of genotype of regional white matter in either of the two cohorts.
Conclusions. Our ﬁndings demonstrate effects of ZNF804A genetic variation on brain structure, with diverging regional
effects in schizophrenia patients and healthy controls in frontal and temporal brain areas. These effects, however, might
be dependent on the impact of other (genetic or non-genetic) disease factors.
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Introduction
Schizophrenia has a substantial genetic basis, and a
signiﬁcant number of these genetic risk variants have
recently been identiﬁed through genome-wide ana-
lyses (Sullivan et al. 2012). The mechanisms through
which variation in risk genes, copy number variants,
or rare mutations affect the developing brain and inter-
act in its arising pathophysiology are still far from
being clear. The ZNF804A gene (coding for zinc
ﬁnger protein 804A) has been suggested to harbour
common risk variants for schizophrenia (O’Donovan
et al. 2008), which has been replicated in several studies
across different ethnic groups (Li et al. 2012; Zhang
et al. 2012; Schwab et al. 2013). The rs1344706 single
nucleotide polymorphism (SNP) has been of particular
interest, as it has been linked to brain structural, func-
tional and cognitive variation (Donohoe et al. 2010).
Two recent studies have shown an impact of
ZNF804A rs1344706 genetic variation on cognitive
function and brain activation patterns in tasks related
to cognitive control (Thurin et al. 2013) and working
memory for faces (Linden et al. 2013), respectively, as
well as connectivity measures in healthy subjects
(Paulus et al. 2013). As such functions are putative
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endophenotypes for schizophrenia, the link to
ZNF804A might provide an understanding on how
the gene or gene products act on the biological sub-
strates of psychosis, including schizophrenia and
other psychiatric disorders (Donohoe et al. 2010; Hess
& Glatt, 2014).
ZNF804A might, however, also affect brain develop-
ment; hence, brain structural changes related to vari-
ation in one or more SNPs may thus reﬂect an
enduring impact of the gene’s function (Donohoe
et al. 2010). A ﬁrst volumetric study of ZNF804A
(rs1344706) in healthy subjects showed larger total
white matter volumes in risk-allele carriers along
with reduced grey matter in the angular gyrus, para-
hippocampal gyrus, posterior cingulate and medial
orbitofrontal gyrus (Lencz et al. 2010). A subsequent
volumetric study in schizophrenia patients and healthy
controls demonstrated an effect of the same marker on
total and frontal white matter volume in schizophrenia
patients (risk-allele carriers having larger volumes),
but only total white matter volume in healthy controls
(Wassink et al. 2012). A more detailed recent voxel-
based morphometry (VBM) study also revealed effects
on regional grey matter in schizophrenia patients and
healthy controls (Donohoe et al. 2011), whereby homo-
zygous risk-allele carriers for rs1344706 differed in
regional grey matter of the dorsolateral prefrontal
cortex, hippocampus and amygdala compared with
heterozygotes and non-risk-allele homozygotes. This
last study, in particular, also suggested that effects of
this polymorphism might, in fact, diverge markedly
between healthy controls and schizophrenia patients,
i.e. that effects vary both regionally and in direction,
such as ﬁndings of increased hippocampal grey matter
in risk-allele homozygotes in the patient sample, but
not within the control sample (Donohoe et al. 2011).
Similarly, we found cortical thickness to show disso-
ciated effects in patients and controls (Schultz et al.
2014), with risk-allele carriers within the patient
group having thicker prefrontal and temporal cortices,
while in the healthy control group risk-allele homo-
zygotes had thinner cortices. Despite the existing
evidence, the effects and regional distribution
remain unclear, and as with many other imaging gen-
etics ﬁndings in schizophrenia, there is a lack of
replication.
In the present study, we aimed to extend the evi-
dence for effects of rs1344706 and its risk allele (A)
on brain structure in both healthy controls and schizo-
phrenia subjects by using VBM to map regional brain
structural differences on a voxel-by-voxel basis, with
the particular emphasis to replicate and extend the pre-
vious ﬁndings on (a) the regional pattern of effects, and
(b) the divergence of effects between schizophrenia
patients and healthy controls.
Method
Subjects
We included 62 patients with a Diagnostic and
Statistical Manual of Mental Disorders, fourth edition
(DSM-IV) diagnosis of schizophrenia (44 male,
18 female; mean age 31.6 years, S.D.=11.5 years; all on
stable antipsychotic medication) and 54 healthy con-
trols from the community (29 male, 25 female; mean
age 29.5 years, S.D.=9.9 years), who had no current or
previous psychiatric treatment or diagnosis. All sub-
jects provided written informed consent to a study
protocol approved by the Jena Medical School Ethics
Committee, in accordance with the Declaration of
Helsinki. Groups did not differ in age (t test: p=0.291,
two-tailed) or gender (χ2 test: p=0.055). Groups
differed in overall performance on the MWT-B
(Mehrfachwahl-Wortschatz-Intelligenztest B), an esti-
mate of pre-morbid intelligence quotient (IQ) [avail-
able for 58 schizophrenia patients and 37 controls;
analysis of variance (ANOVA): F=9.312, p=0.003].
None of the subjects had any major medical or neuro-
logical condition. Part of this sample has been used in
a recent analysis of ZNF804A effects on cortical thick-
ness (Schultz et al. 2014), whereas for the present ana-
lysis, the sample has been expanded to allow analysis of
a larger cohort with another methodological approach.
Genotyping using Sanger sequencing
Individual genotypes for the studied polymorphism
were retrieved from sequence data generated by
Sanger sequencing. Genomic DNA sequences covering
rs1344706 and theﬂankingup- anddownstream regions
were retrieved from the UCSC Genome Browser
based on the human genome build GRCh37/hg19
(http://genome.ucsc.edu/cgi-bin/hgGateway). Primer
design was performed by keeping a minimum distance
of about 150 base pairs (bp) up- and downstream from
the target base. Primer sequences are obtainable from
the authors upon request. Amplicons were generated
under standard polymerase chain reaction (PCR) condi-
tions. Resequencing was carried out with BigDye
v3.1 (Applied Biosystems, USA) sequencing reagents
employed according to the manufacturer’s protocol.
Data were generated on the Applied Biosystems
3130xl Genetic Analyzer, and SeqMan II (DNASTAR
Inc., USA) software was used for data visualization.
Electropherograms were evaluated independently by
two raters.
Genotype distribution in schizophrenia patients
was 23, 33 and six for AA, CA and CC, respectively,
and 19, 28 and seven in healthy controls. Genotype dis-
tributions did not deviate signiﬁcantly from Hardy–
Weinberg equilibrium in patients and controls
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(ppatients =0.234, pcontrols =0.504). The rs1344706 minor
(C) allele frequency (MAF) observed in our samples
(MAF=0.375) was very similar to the MAF observed
in 1000 Genomes (MAF=0.393; http://www.1000genomes.
org/). ANOVA with the factors diagnosis and geno-
type did not show effects of diagnosis (p=0.758), genotype
(p=0.188) or their interaction (p=0.543) on the variable
age. For pre-morbid IQ estimates (see above, available
for 58 patients and 37 controls), there was also no effect
of genotype (p=0.496), or diagnosis x genotype interaction
(p=0.114), but only for factor diagnosis (as shown above).
Magnetic resonance imaging (MRI) and VBM
We obtained T1-weighted high-resolution MRI scans
on a 1.5 T Siemens Magnetom Vision plus system
(Siemens, Germany) using a three-dimensional Fast
Low Angle SHot (FLASH) sequence (repetition time=
15ms, echo time=5ms, ﬂip angle α=30°, 192 sagittal
slices, ﬁeld of view=256×256mm, with voxel dimen-
sions 1×1×1 mm3). Images were visually inspected
for artefacts and underwent automated quality control
using an algorithm provided in the VBM toolbox
(http://dbm.neuro.uni-jena.de/vbm8/).
For post-processing and VBM analysis, we used
the VBM8 toolbox, a freely available toolbox based
on Statistical Parametric Mapping software SPM8
(Institute of Neurology, UK) and Matlab (Mathworks,
USA). VBM8 is based on the general VBM approach
proposed by Ashburner & Friston (2000, 2005), imple-
menting the Diffeomorphic Anatomical Registration
Through Exponentiated Lie Algebra (DARTEL) algor-
ithm for non-linear normalization (Ashburner, 2007).
Grey matter and white matter maps were extracted
from MRI data for each subject and underwent non-
linear normalization using DARTEL. We deﬁned an
internal grey matter threshold of 0.2 for both grey mat-
ter maps and white matter maps, thus choosing a more
conservative value to limit edge effects. Smoothing
was performed with a 12mm full-width at half-
maximum (FWHM) Gaussian kernel for grey matter
maps and 20mm FWHM for white matter maps. The
Anatomical Automatic Labeling (AAL) toolbox was
used for anatomical labelling (Tzourio-Mazoyer et al.
2002). In addition to regional analysis of grey and
white matter, the VBM toolbox also estimates total
brain grey matter and white matter volume by assign-
ing the corresponding number of voxels to either tissue
type multiplied by the voxel volumes, thus allowing
analysis of effects of genotype on global parameters
as well.
Statistical analysis
We ﬁrst used multivariate ANOVA (with SPSS 20;
IBM, USA) to test effects of genotype on total brain
grey matter and total white matter volumes by
deﬁning the factors group (schizophrenia; controls)
and genotype (AA; CA; CC) and the covariates age
and gender (to remove variance related to these vari-
ables), and using Pillai’s trace.
VBM statistics were carried out in SPM8 using a gen-
eral linear model deﬁning diagnostic group (schizo-
phrenia; healthy control) and genotype (AA; CA; CC)
while using age and gender as covariates (again, to re-
move their effect on variance) and applying a height
threshold of p<0.001 (uncorrected) throughout all
analyses. This choice of threshold was based on the
existence of previous VBM analyses, as mentioned
above, and thus allowed us to either replicate (or re-
fute) previous ﬁndings in these mentioned areas,
while whole-brain testing allowed us to expand ana-
lysis to other areas as well. Our main hypothesis of
divergent effects of rs1344706 was tested with an inter-
action of group x genotype; furthermore, we also
tested effects of genotype in schizophrenia patients
and effects of genotype in healthy controls separately;
we performed each of these three tests for both grey
and white matter, respectively.
Results
Total brain grey matter and white matter
Overall multivariate ANOVA (for grey matter and
white matter) revealed no signiﬁcant effect of factor
diagnosis (F2,107=0.223, p=0.801) or genotype (F4,216=
1.831, p=0.124), but a signiﬁcant diagnosis x genotype
interaction (F4,216=3.109, p=0.016). Tests of between-
subject effects revealed signiﬁcant group differences
only for the interaction of diagnosis x genotype for
total brain white matter (F2,116=3.318, p=0.04), but
not for grey matter (F2,216=1.267, p=0.286) and neither
for grey nor white matter for the diagnosis or genotype
effects alone. Both age and gender had signiﬁcant
effects on total brain grey matter and white matter,
respectively (both p<0.001).
VBM analysis of grey matter
In schizophrenia patients, there were several sig-
niﬁcant regional effects of genotype on grey matter
(see Fig. 1), including the left temporal pole and an-
terior part of the inferior temporal gyrus, bilateral lat-
eral temporal cortices, right superior temporal and
supramarginal gyri, bilateral inferior prefrontal gyri,
left medial cerebellum, left orbitofrontal cortex and
posterior right thalamus.
In healthy controls, we found several signiﬁcant re-
gional effects of genotype (see Fig. 2), including the
left middle temporal gyrus (lateral temporal cortex),
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right insular cortex, left orbitofrontal cortex and right
superior temporal cortex.
The interaction analysis of diagnosis x genotype for
regional grey matter also resulted in signiﬁcant
ﬁndings (see Fig. 3) in some of the above-mentioned
clusters. Of note, parts of three of these clusters actu-
ally showed signiﬁcance levels that also survived
family-wise error (FWE) correction for multiple com-
parisons (as implemented in SPM, peak-level): one
cluster in the left orbitofrontal cortex (coordinates
−6, 62, −20; FWE-corrected p=0.021), right middle/
superior temporal gyrus (69, −39, 6; FWE-corrected
p=0.029) and left middle temporal gyrus (−68, −39,
3; FWE-corrected p=0.034) (see Table 1 and Fig. 4).
Fig. 1. Voxel-based morphometry analysis of effects of ZNF804A genotype (rs1344706) on grey matter in schizophrenia
patients (p<0.001, uncorrected).
Fig. 2. Voxel-based morphometry analysis of effects of ZNF804A genotype (rs1344706) on grey matter in healthy controls
(p<0.001, uncorrected).
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Results of group comparison of grey matter differ-
ences between patients and healthy controls are pro-
vided in online Supplementary Fig. S1.
In addition to the above results, we inspected the
plots for proﬁles of genotype-related changes, i.e. to
identify the subgroup contributing most to the effects.
Assessing the distribution of grey matter values across
the groups, a rather consistent pattern emerged.
For the interaction analysis, the effect was caused by
smaller grey matter values for AA homozygotes (com-
pared with AC heterozygotes) in the healthy control
group, whereas in the schizophrenia group grey matter
values for AA homozygotes were higher compared
with AC heterozygotes. The CC homozygotes often
took an intermediary position. However, these sub-
groups were very small, thus making direct compari-
son more difﬁcult. For the genotype effects within
each group, we found that AA homozygotes in the
schizophrenia group had higher grey matter values
than the AC heterozygotes across all signiﬁcant larger
clusters. Within the healthy control group analysis, in-
spection of plots also conﬁrmed smaller grey matter
values for AA homozygotes (in signiﬁcant clusters)
in contrast to AC heterozygotes (except for the anterior
insula cluster, where the two groups were similar, but
CC homozygotes showed larger effects), thus conﬁ-
rming the overall pattern of an inverted (or diverging)
effect of AA versus AC carrier status in schizophrenia
patients versus controls.
VBM analysis of white matter
There were no signiﬁcant effects of genotype on white
matter in either schizophrenia patients or healthy
controls, and no signiﬁcant effects of a diagnosis x
genotype interaction for white matter (all at the
predeﬁned threshold of p<0.001).
Discussion
As its main result, our study identiﬁed effects of
ZNF804A on regional brain structure in the left orbito-
frontal and left and right lateral temporal cortices with
a signiﬁcant diagnostic group x genotype interaction.
In these regions, variation in rs1344706 led to diver-
ging effects in patients and controls. Further major ef-
fects (at uncorrected levels of signiﬁcance) were seen in
multiple frontal, temporal and parietal cortical areas,
where the gene’s impact was different for the two diag-
nostic groups. While these ﬁndings add to the increas-
ing identiﬁcation of brain structural effects of this
schizophrenia risk gene, they partially conﬁrm a pecu-
liar effect of this SNP. This effect is related to the mark-
edly different impact of the SNP in patients and
healthy subjects. Previous morphometry studies have
already suggested such effects on grey matter density
(Donohoe et al. 2011), as well as on cortical thickness
in our own previous work (Schultz et al. 2014). There
is also increasing evidence for ZNF804A effects
Fig. 3. Voxel-based morphometry analysis of interaction effects of ZNF804A genotype (rs1344706) x diagnostic group
(schizophrenia; healthy controls) (p<0.001, uncorrected).
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on brain function. Two recent electroencephalography
(EEG) studies revealed an impact of rs1344706 on P300
amplitude/responses (Del Re et al. 2014; O’Donoghue
et al. 2014).
Imaging genetics studies have generally aimed to
evaluate the effect of particular risk genes (or risk
scores) on brain structures. Often, however, it is
unclear how gene expression or gene products might
inﬂuence brain structure in later life. For ZNF804A,
there is growing evidence that effects start during
early brain development. This has been shown in
fetal brains, where rs1344706 variation had a strong
impact on ZNF804A allelic expression during the
second trimester of intra-uterine development, but
not in adult brains (Hill & Bray, 2012). Expression in
postmortem brains seems to differ between patients
and healthy controls, but this observation is only
incompletely understood (Okada et al. 2012;
Table 1. Anatomical overview of regions with signiﬁcant effects (p<0.001, uncorrected) in voxel-based morphometry analysis of ZNF804A
(rs1344706) genotype effects (only clusters with at least k=10 voxels listed) in schizophrenia patients, healthy controls, and interaction effects of
diagnosis x genotype
Anatomical region
MNI coordinates of
maximum voxel: x, y, z
k, number
of voxels
Genotype effects in schizophrenia patients (p<0.001)
Left inferior temporal cortex −50, −3, −45 1180
Right inferior (/middle) temporal cortex 64, −40, −17 664
Right supramarginal gyrus, superior temporal cortex 69, −37, 4 907
Right inferior frontal gyrus 58, 21, 3 252
Left cerebellum −42, −78, −23 151
Left medial orbitofrontal cortex −8, 66, −11 120
Right middle temporal gyrus 66, −1, −17 438
Right middle temporal/middle occipital cortex 48, −69, 7 181
Left lower cerebellum −14, −81, −50 101
Left inferior frontal gyrus −51, 15, 28 31
Left rolandic operculum/temporal pole −56, 8, 0 120
Left inferior temporal cortex −48, −25, −33 79
Right inferior temporal cortex 58, −1, −39 33
Right temporal pole/superior temporal gyrus 62, 3, 1 12
Right thalamus 12, −25, 6 70
Genotype effects in healthy controls (p<0.001)
Left middle temporal gyrus −68, −34, 1 181
Right insula 33, 15, 6 770
Left superior orbitofrontal cortex/gyrus rectus −9, 57, −23 233
Right superior temporal gyrus 69, −39, 9 45
Left middle occipital cortex −24, −60, 36 42
Interaction effects of diagnosis x genotype (p<0.001)
Left gyrus rectus/orbitofrontal cortex −6, 62, −10* 1291*
Right middle/superior temporal gyrus 69, −39, 6* 371*
Left middle temporal gyrus −68, −39, 3* 834*
Vermis/left cerebellum 2, −40, −12 651
Right supramarginal gyrus 42, −37, 37 217
Right insula 32, 17, 7 950
Right inferior/middle temporal gyrus 52, −39, −15 364
Right insula 34, −7, 9 199
Right superior/middle frontal gyrus 20, 60, 3 535
Right middle temporal/occipital cortex 50, −72, 7 160
Right middle temporal gyrus 63, −4, −21 119
Right lingual gyrus 9, −61, −3 76
Left inferior temporal cortex −42, −6, −42 20
Left middle occipital cortex −38, −78, 3 11
MNI, Montreal Neurological Institute.
* Parts of these clusters are also signiﬁcant at p<0.05, family-wise error corrected.
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Schultz et al. 2014), as is the regional pattern of physio-
logical expression (Buonocore et al. 2010). Also, recent
studies suggest an indirect action of ZNF804A by
modulating the gene expression of other risk genes
(Girgenti et al. 2012).
While in many instances genetic risk factors have
demonstrated stronger impact of a particular risk
gene in patients compared with controls, this might
not be the case (at least not generally) for rs1344706.
While the mentioned VBM study of Donohoe et al.
(2011) reported preserved brain structure in patients,
one volumetric study found larger regional white mat-
ter volumes in risk-allele carriers, together, however,
with more severe psychotic symptoms (Wassink et al.
2012). In contrast, a large study of healthy subjects
did not ﬁnd statistically signiﬁcant effects on brain
structure (Cousijn et al. 2012). Given that volumetry,
VBM and analysis of cortical thickness assess three
different aspects of brain morphometry, our ﬁndings
are most comparable with the studies of Donohoe
et al. (2011) with respect to methods. In fact, these
authors analysed schizophrenia and healthy control
cohorts of roughly similar size to ours (using the
older VBM5 toolbox). While their regional ﬁndings
only partially overlap with ours (including anterior
temporal pole and temporal cortical areas, although
with somewhat different location), they also share
similarities. The authors reported that AA risk homo-
zygotes showed opposite effects in patient versus con-
trol groups, with higher grey matter density for AA
homozygotes in patients, but not controls. Similarly,
effects of ZNF804A on cortical thickness have received
support from two recent studies (Voineskos et al. 2011;
Schultz et al. 2014), though there has been also one
failure to replicate (Bergmann et al. 2013).
Functional studies, however, do suggest effects of
ZNF804A genotypes in patients to exceed those seen
in healthy controls (Rasetti et al. 2011). Given that
there are also a number of studies demonstrating ef-
fects of rs1344706 in healthy subjects (Esslinger et al.
2009; Walter et al. 2011; Linden et al. 2013; Mohnke
et al. 2014), further studies might elucidate (within
the same cohort) the interaction of structural and func-
tional effects.
Our study failed to identify any affects of ZNF804A
on white matter density. Although VBM of white mat-
ter is inferior to diffusion tensor imaging (DTI) appli-
cations, which captures also quantitative measures
of white matter damage (e.g. assessing fractional ani-
sotropy), our results ﬁt into the current literature on
ZNF804A and white matter tracts. Previous DTI
studies have mostly failed to conﬁrm a clear impact
of ZNF804A on white matter architecture or fractional
anisotropy measures (Voineskos et al. 2011; Sprooten
Fig. 4. Render view of voxel-based morphometry analysis of interaction effects of ZNF804A genotype (rs1344706) x diagnostic
group (schizophrenia; healthy controls) (p<0.05, family-wise error correction for multiple comparisons).
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et al. 2012; Wei et al. 2013). One previous white
matter VBM study (of T1-weighted MRI) suggested
an interaction of group and genotype (rs1344706) in
left prefrontal white matter (Wei et al. 2012), but our
study did not replicate this ﬁnding. In two more recent
studies, one found lower fractional anisotropy in
risk-allele carriers in several regions including the
corpus callosum and left forceps minor (Ikuta et al.
2014), while a second study failed to show any signiﬁ-
cant impact of ZNF804A on white matter microstruc-
ture in a large healthy subject sample (O’Donoghue
et al. 2014).
Conclusions
In conclusion, our study provides evidence for sig-
niﬁcant divergence of ZNF804A (rs1344706) effects on
grey matter in prefrontal and temporal brain areas.
Effects of prefrontal, temporal and parietal grey matter
differ not only according to genotype, but the
genotype-related effects are different between schizo-
phrenia patients and controls. There was, however,
no effect on white matter density. While our results
conﬁrm divergence of structural effects across different
groups, further studies are needed to clarify the micro-
structural changes underlying these effects.
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